Neha Mehta-Shah, MD, MSCI

Articles by Neha Mehta-Shah, MD, MSCI

Neha Mehta-Shah, MD, Weighs in on SWOG 1826 Data, Implications at 2023 ASCO Annual Meeting

Chadi Nabhan, MD, MBA, FACPMeeting News | June 7, 2023

The study compared nivolumab plus AVD with brentuximab vedotin plus AVD in advanced stage classic Hodgkin lymphoma.

Neha Mehta-Shah, MD, MSCI, on Bispecific Antibodies in B-cell Lymphomas, at ASH 2022

Cecilia BrownMeeting News | January 10, 2023

Neha Mehta-Shah, MD, MSCI, discusses bispecific antibodies in B-cell lymphomas.